Drugs / MPA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00242710 Comparator | Sep 2005 → Sep 2008 | endometrial disorder, osteoporosis | Pfizer | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MPA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00242710 ↗ |